MMSET Is Associated with Prostate Cancer Progression and Over-Expressed in Androgen Independent Metastatic Prostate Cancer.
R Mehra, I Asangani, R Lonigro, X Cao, NE Philips, K Suleman, S Varambally, MA Rubin, RB Shah, KJ Pienta, AM Chinnaiyan - University of Michigan, Ann Arbor; Weill Cornell Medical College, New York; Caris Life Sciences, Irving
Does Gleason Grade Progress over Time?
MJ Stampfer, K Penney, J Sinnott, R Flavin, J Stark, S Finn, E Giovannucci, H Sesso, M Loda, L Mucci, M Fiorentino - Dana Farber/Harvard Cancer Center, Boston, MA
Do Patients with Multiple Positive Cores of Gleason Score 6 (GS6) Adenocarcinoma on Biopsy Have Unfavorable Findings at Radical Prostatectomy (RP)?
CL Ellis, JI Epstein - The Johns Hopkins Hospital, Baltimore
Potential Impact of Gleason Grade Reproducibility on Active Surveillance Management in Prostate Cancer: A Multi-Institutional Study of Patients Enrolled in a Prospective Active Surveillance Study (PASS).
JK McKenney, J Simko, M Bonham, LD True, S Hawley, L Newcomb, PASS Pathology Group, PR Carroll, JD Brooks - Stanford, Stanford, CA; University of California, San Francisco; University of Washington, Seattle; Canary Foundation, Palo Alto, CA
Global Gleason Score on Prostate Needle Biopsies as Predictor of Prostatectomy Gleason Score: Comparison with Highest Gleason Score, Greatest-Percent and Largest-Length Gleason Scores.
MM Shevchuk, A Strivastava, A Tewari - Weill Cornell Medical College, New York, NY
Focal Prostate Atrophic Lesions and Risk of Lethal Prostate Cancer.
S Davidsson, M Fiorentino, O Andren, F Fang, LA Mucci, E Varenhorst, K Fall, JR Stark - Orebro University Hospital, Orebro, Sweden; Bologna University, Italy; Brigham & Women's Hospital, Boston, MA; Harvard School of Public Health, Boston, MA; Linkoping University Hospital, Linkoping, Sweden; Karolinska Institute, Stockholm, Sweden
Does the Sextant Site of Atypical Small Acinar Proliferation on Initial Prostate Needle Biopsy Predict Sextant Site of Cancer on Follow-Up Prostate Needle Biopsy?
JL Merrimen, G Jones, A Rocker, JR Srigley - Dalhousie University, Halifax, Canada; McMaster University, Hamilton, Canada; Mount Sinai Hospital, Toronto, Canada
Initial High Grade Prostatic Intraepithelial Neoplasia (HGPIN) with Carcinoma on Subsequent Prostate Needle Biopsy: Findings at Radical Prostatectomy.
T Alhussain, J Epstein - The Johns Hopkins Hospital, Baltimore, MD
High-Grade Prostatic Intraepithelial Neoplasia (HGPIN): Preinvasive Lesion of Adenocarcinoma (CA) or Epiphenomenon? A Topographic Study of HGPIN and CA in Radical Prostatectomies (RP).
AAAV Brasil, A Billis, L Meirelles, LLL Freitas, PH Poletto, P Zubioli, WJ Favaro, VHA Cagnon, LO Reis, U Ferreira - School of Medicine, University of Campinas (Unicamp), SP, Brazil
Perineal Mapping Biopsy of Prostate: Experience from a Single Academic Institution and Impact on Prostate Cancer Management.
LP Kunju, R Siddiqui, M Rowley, D Miller, S Meyers, D Wood, JT Wei - University of Michigan, Ann Arbor
Inflammation Confined to the Stromal Compartment in Benign Prostate Biopsy May Be Associated with Decreased Risk of Subsequent Prostate Cancer (PCa).
BA Rybicki, A Rundle, D Tang, NS Gupta, DA Chitale, ON Kryvenko - Henry Ford Hospital, Detroit, MI
Risk of Prostatic Carcinoma Following a Diagnosis of Atypical Small Acinar Proliferation: A Multicenter Retro-Respective Study.
MY Gabril, B Moussa, S Metias, MS Moussa, GM Yousef - London Health Sciences Center/ University of Western Ontario, ON, Canada; St Michael's Hospital/University of Toronto, ON, Canada
The Diagnosis of Clear Cell Renal Cell Carcinoma (CRCC) on Needle Core Biopsies (NCB) of the Kidney: How Specific Is Carbonic Anhydrase IX (CA9) Immunohistochemistry (IHC)?
R Goyal, B Zhu, S Bishu, V Parimi, X Lin, XJ Yang, SM Rohan - Northwestern University Feinberg School of Medicine, Chicago, IL
Expression of Putative Stem Cell Markers CD133 and Oct-4 in Papillary Renal Cell Carcinoma and Its Prognostic Significance.
K Kim, JY Ro, YM Cho - Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Renal Cell Carcinoma with Extensive Clear Cell Component and Papillary Architecture: Value of Immunohistochemistry.
L Duan, RF Youssef, V Margulis, Y Lotan, P Koduru, W Kabbani, P Kapur - University of Texas Southwestern Medical Center, Dallas
Renal Mucinous Tubular and Spindle Cell Carcinoma: Expanding Our Knowledge of Immunohistochemical and Cytogenetic Findings.
AR Laury, M Riveros-Angel, VS Sabbisetti, P Dal Cin, MS Hirsch - Brigham and Women's Hospital, Boston, MA
Subtyping of Papillary Renal Cell Carcinoma (PRC) by Fine Needle Aspiration (FNA): A Reliable Approach To Providing Valuable Prognostic Information.
GE Parks, SJ Sirintrapun, KR Geisinger - Wake Forest University School of Medicine, Winston-Salem, NC
Relationship between Sporadic Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) and Renal Angiomyoadenomatous Tumor (RAT) of the Kidney: Analysis by Virtual-Karyotyping, Fluorescent In Situ Analysis and Immunohistochemistry (IHC).
A Behdad, FA Monzon, O Hes, M Hirsch, M Michal, E Comperat, P Camparo, P Rao, M Picken, R Montironi, C Annaiah, LP Herrera, K Arora, DE Westfall, P Tamboli, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; The Methodist Hospital, Houston, TX; Charles University, Plzen, Czech Republic; l'Hotel-Dieu, Place du Parvis, Paris, France; Hopital Foch, Suresnes, France; Brigham and Women's Hospital, Boston, MA; MD Anderson Cancer Center, Houston, TX; Loyola University Hospital, Chicago, IL; Polytechnic University of the Marche Region, Ancona, Italy
Clear Cell Papillary Renal Cell Carcinoma and XP11.2 Translocation-Associated Renal Cell Carcinoma Are Derived from Distal Nephron Tubules and Proximal-Tubules Respectively.
PL Zhang, MB Amin - William Beaumont Hospital, Royal Oak, MI
Sporadic Hybrid Oncocytic/Chromophobe Tumor (HOCT) of the Kidney . The Quest To Define It Continues!.
K Trpkov, M Brunelli, G Martignoni, A Yilmaz - University of Calgary, AB, Canada; Universita di Verona, Verona, Italy
Renal Small Cell Oncocytoma with Pseudosettes . A Histomorphologic, Immunohistochemical, Ultrastructural and Molecular Genetic Study of 10 Cases.
FB Petersson, T Vanecek, M Michal, N Kuroda, M Hora, O Hes - Charles University and University Hospital, Plzen, Czech Republic; National University Health System, Singapore, Singapore; Red Cross Hospital, Kochi, Japan
Correlation of Recently Proposed Chromophobe Tumor Grade (CTG) with Initial Stage in 82 Chromophobe Renal Cell Carcinomas (RCC) from a Single Institution.
E Weinzierl, B Chung, J McKenney - Stanford, Stanford, CA
7q31 (C-MET) Amplification Is a Constant Finding in Tubulo-Cystic Renal Cell Carcinoma.
M Brunelli, D Segala, S Gobbo, S Bersani, E Bragantini, M Gardiman, I Alvarado Cabrero, M Chilosi, G Martignoni - University of Verona, Italy; S. Chiara Hospital, Trento, Italy; Univeristy of Padua, Italy; Centro Medico, Mexico City, Mexico
Calcium Oxalate Crystals Are Present in Acquired Cystic Kidney Disease in End-Stage Renal Disease (ACKD-ESRD) but Not in Autosomal Dominant Polycystic Kidney Disease (ADPKD) . Does This Signify a Role in Cancer Development?
MM Picken, V Mehta - Loyola University Medical Center, Maywood, IL
Comparison of the Pathologic Spectrum of Neoplasia in Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Acquired Cystic Kidney Disease in End-Stage Renal Disease (ACKD-ESRD).
MM Picken, V Mehta - Loyola University Medical Center, Maywood, IL
Affymetrix Genechip Microarray Analysis of Renal Cell Carcinoma in Formalin Fixed Paraffin Embedded Tissue.
K Fisher, AN Young, Q Yin-Goen, AO Osunkoya - Emory University Scool of Medicine, Atlanta
miR-210 (Hypoxia-Responsive) a Marker of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
VA Valera Romero, BA Walter Rodriguez, M Sobel, WM Linehan, MJ Merino - National Cancer Institute, NIH, Bethesda
Renal Cell Carcinoma with Novel VCL-ALK Fusion: New Representative of ALK-Associated Tumor Spectrum.
L Debelenko, S Raimondi, N Daw, B Shivakumar, M Nelson, D Huang, J Bridge - St. Jude Children's Hospital, Memphis, TN; Nebraska Medical Center, Omaha
Renal Translocation t(6;11) Carcinoma: A Study on 5 Cases Using Histomorphology, Immunohistochemistry, Ultrastructure and Molecular Genetic Techniques.
FB Petersson, T Vanecek, M Michal, G Martignoni, M Brunelli, D Spagnolo, N Kuroda, X Yang, I Alvarado Cabrero, M Hora, O Hes - Charles University and University Hospital, Plzen, Czech Republic; National University Health System, Singapore, Singapore; University of Verona, Italy; PathWest Laboratory Medicine WA, Nedlands, Australia; Red Cross Hospital, Kochi, Japan; North West University Chicago, IL; Centro Medico, Mexico City, Mexico
Clinical Significance of miR-21 in Renal Cell Carcinoma.
H Faragalla, Y Youssef, B Kahalil, NMA White, S Mejia-Guerrero, C Streutker, M Jewett, G Bjarnason, L Sugar, MI Attalah, GM Yousef - Li Ka Shing Knowledge Institue St. Michael's Hosptial, Toronto, ON, Canada; Princess Margaret Hospital, Toronto, ON, Canada; Sunnybrook Health Sciences Center, Toronto, ON, Canada; University of Toronto, ON, Canada
microRNA Expression and mRNA Transcripts in Clear Cell (Conventional) Renal Cell Carcinoma.
AH Hughes, G Sharma, S Roy, JM Krill-Burger, CM Sciulli, MA Lyons, LA Kelly, AV Parwani, R Dhir, T McHale, WA LaFramboise, SI Bastacky - UPMC, Pittsburgh, PA
microRNA Profiling in Clear Cell Renal Cell Carcinoma: Biomarker Discover and Identification of Potential Controls and Consequences of miRNA Dysregulation.
NMA White, TT Bao, J Grigull, YM Youssef, A Girgis, M Diamandis, E Fatoohi, M Metias, RJ Honey, R Stewart, KT Pace, GA Bjarnason, GM Yousef - Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; University of Toronto, ON, Canada; York University, Toronto, ON, Canada; St. Michael's Hospital, Toronto, ON, Canada; Sunnybrook Odette Cancer Center, Toronto, ON, Canada
microRNA Profiling in Kidney Cancer: Accurate Molecular Classification of Subtypes and Correlation with Cytogenetic and mRNA Data.
YM Youssef, NMA White, J Grigull, A Krizova, C Samy, S Mejia-Guerrera, A Evans, GM Yousef - University of Toronto, ON, Canada; Li Ka Shing Knowledge Institute, Toronto, ON, Canada; York University, Toronto, ON, Canada; Toronto General Hospital, ON, Canada
Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma.
S Ali, VA Master, A Abbasi, O Kucuk, AN Young, K Ogan, JG Pattaras, PT Nieh, FF Marshall, AO Osunkoya - Emory University School of Medicine, Atlanta, GA
Invasive Urothelial Carcinomas of the Renal Pelvis Show Immunohistochemical Expression for PAX8 and PAX2 in a Subset of Cases.
J Hughes, AR Sangoi, JK McKenney - Stanford, Stanford, CA; El Camino Hospital, Mountain View, CA
Role of Immunohistochemistry (IHC) in the Differential Diagnosis of Invasive Urothelial Carcinoma (UCa) Versus High-Grade Tumors of the Renal Collecting System [Collecting Duct Carcinoma (CDC) and Renal Medullary Carcinoma (RMC)].
C Annaiah, GP Paner, AM Gown, C Gulmann, M Amin, AO Osunkoya, M Vankalakunti, LP Herrera, R Gupta, K Arora, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; University of Chicago, IL; PhenoPath Laboratories, Seattle, WA; William Beaumont Hospital, Detroit, MI; Emory University Hospital, Atlanta, GA
Immunohistochemical (IHC) Expression of Carbonic Anhydrase IX (CA9) in Papillary (PRCC) and Chromophobe (CHRCC) Renal Cell Carcinoma Is Associated with Necrosis.
R Goyal, B Zhu, V Parimi, S Bishu, X Lin, XJ Yang, SM Rohan - Northwestern University, Chicago, IL
Gain of Chromosome 12 Is an Adverse Prognostic Factor for Clinically Localized Clear Cell Renal Cell Carcinoma: A Chromogenic In-Situ Hybridization (CISH) Study.
H He, P Elson, H Aydin, S Campbell, B Rini, C Magi-Galluzzi, R Tubbs, M Zhou - Cleveland Clinic; Peking University, Health Science Center, Beijing, China
Carbonic Anhydrase IX Is an Independent Prognostic Predictor for Clinically Localized Clear Cell Renal Cell Carcinoma.
H He, P Elson, H Aydin, S Campbell, B Rini, C Magi-Galluzzi, M Zhou - Cleveland Clinic; Peking University, Health Science Center, Beijing, China
Prognostic Significacne of MTORC1 Immunoexpression in Clear Cell (Conventional) Renal Cell Carcinoma.
P Kapur, D Rakheja, RF Yousse, V Margulis, W Kabbani, Y Lotan - UT Southwestern Medical Center, Dallas, TX
Prognostic Values of Histologic Subtype and Other Clinicopathologic Features: A Study of 961 Patients with Renal Cell Carcinomas Treated by Radical Nephrectomy.
SS Shen, JY Ro, LD Truong, AG Ayala - The Methodist Hospital and Weill Medical College of Cornell University, Houston, TX
MLH1 and PMS2 Define Prognosis in Sporadic Urothelial Carcinoma of Renal Pelvis and Ureter.
L Andres, L Zaldumbide, A Gaafar, J Gonzalez, A Garcia Tello, JC Angulo, JI Lopez - Hospital de Cruces, University of the Basque Country, Barakaldo, Spain; Hospital de Mendaro, Spain; Hospital de Getafe, Spain
Chromosomal Imbalances Identify Pathways Associated with Resistance to Antiangiogenic Therapy in Clear Cell Renal Cell Carcinoma.
FA Monzon, K Alvarez, L Peterson, K Sircar, P Tamboli, E Jonasch - The Methodist Hospital, Houston, TX; The Methodist Hospital Research Institute, Houston, TX; MD Anderson Cancer Center, Houston, TX
Clinicopathologic Characteristics and Outcomes of Renal Cell Carcinoma: A Single Center Experience.
P Kapur, R Youssef, F Alhalabi, V Margulis, Y Lotan, W Kabbani - UT Southwestern Medical Center, Dallas, TX
Histology-Radiology Correlation in Metastatic Clear Cell Renal Cell Carcinoma Treated with Pre-Operative Sorafenib and Nephrectomy.
W Dubinski, TK Kim, JJ Knox, A Finelli, AJ Evans - University Health Network, Toronto, ON, Canada
Growth Pattern: A New Prognostic Parameter of Clear Renal Cell Carcinoma.
T Tsuzuki, A Fukatsu, N Sassa, T Nishikimi, S Katsuno, T Fujita, Y Yoshino, R Hattori, M Gotoh - Nagoya Daini Red Cross Hospital, Japan; Komaki City Hospital, Japan; Nagoya University Hospital, Japan; Okazaki Municipal Hospital, Japan; Chukyo Hospital, Nagoya, Japan
Viability of Glomeruli and Proximity to Tumor in Partial Nephrectomy Specimens for Renal Cell Carcinoma.
ET Lam, A Mortazavi, GS Phillips, D Sharp, D Zynger - The Ohio State University Medical Center, Columbus